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Abstract
Introduction: Nationwide and locally in Los Angeles, CA, uncontrolled diabetes remains a
complex chronic condition within the primary care setting. Chronically uncontrolled diabetes is
costly for patients and health care systems due to high morbidity and mortality rates. As payor
sources move in the direction of providing payment based on core measures and value-based
care, chronic illness programs designed to improve these outcomes must be developed,
implemented, and sustained. The Federally Qualified Health Center (FQHC) in which this
quality improvement project was conducted represents the largest of 11 comprehensive care,
family practice FQHCs in the South-Central Los Angeles area.
Background: A systematic review of available literature was performed. Patient self-monitoring
of blood glucose (SMBG) levels emerged as an evidence-based and reliable patient-driven
intervention promoting improved diabetic care.
Aims and Objectives: The quality improvement project aims are centered around the
improvement of diabetic patient’s self-care behaviors, specifically to improve glycemic control
for uncontrolled diabetic outpatients by implementing a SMBG clinical pathway.
Methods: One primary care provider team within the FQHC implemented a pilot program
utilizing daily patient-driven self-monitoring of blood glucose levels. The pilot team used a
SMBG clinical pathway to guide clinical decision-making for diabetic patients seen within the
provider panel. Patients with an A1c ≥ 10% were offered participation in daily SMBG. The
intervention was implemented over a 6-month period of time and evaluated pre and postintervention A1c measurement and patient/staff satisfaction surveys.
Results: Eighteen patients participated, 72% (n=13) of the participants kept glucose logs and
attended the monthly follow-up visits. Of these, 54% (n=7) reduced their A1c by ≥ 2% and 69%
(n=9) had at least some reduction in A1c. Patients reported improved self-management
knowledge and staff reported satisfaction with the pathway.
Discussion: The use of SMBG improved A1c and self-management for those patients who
continued follow-up, and staff endorsed the value added from the SMBG pathway which
portends well for scaling up the intervention in the setting. Scaling up the SMBG pathway
throughout the 11 clinical locations in the FQHC would benefit diabetic patients whose glucose
is uncontrolled.
Keywords: glucose self-management, glycemic control, Federally Qualified Health Centers,
Latinx population, education, and intervention.
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Implementing a Self-Management Glucose Monitoring Pathway to Improve Glycemic
Control
Introduction
Problem Description
Diabetes Mellitus (DM), a chronic disease causing abnormally high blood glucose levels,
is a leading cause of morbidity and mortality in the United States (CDC, 2020). Approximately
30 million people living in the US have diabetes, and the prevalence of this disease has steadily
risen over the years. About 7 million individuals with DM (hereafter diabetes) were unaware of
their diagnosis and reported not having diabetes when asked (CDC, 2020). People with diabetes
are at higher risk for other chronic diseases and adverse outcomes such as cardiovascular disease,
stroke, vision loss, chronic renal failure, loss of limbs and many other adverse outcomes,
including death. In the United States, diabetes represents the 7th leading cause of death (Centers
for Disease Control and Prevention [CDC], 2020).
Although the prevalence of diabetes is high for all Americans, racial and ethnic
minorities and socioeconomically disadvantaged populations bear a disproportionate disease
burden. American Indian/Alaskan have the highest prevalence of diabetes (15.1%), followed by
Blacks (12.7%), White, non-Latinx (7.4%), and Latinx (2.1%) (CDC, 2020). Educational
attainment, a proxy for socioeconomic status, is also associated with a higher prevalence of
diabetes. Individuals with less than a high school education are at higher risk of developing
diabetes than those with a high school or college education. (Incidence of Newly Diagnosed
Diabetes [CDC], 2020).
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Local Problem
This Quality Improvement (QI) project took place in a Federally Qualified Health Center
(FQHC) in Los Angeles. The clinic serves a largely Latinx community that is economically
disadvantaged and has high rates of low educational attainment. Between 2007 and 2014, the
prevalence of diabetes in the adult population in Los Angeles rose from 10.5% to 14.4% (CDC,
2020). Of those with diabetes in Los Angeles, 29.9% were undiagnosed (LAC-DPH, 2021). The
CDC notes a higher prevalence of diabetes in non-whites in Los Angeles which is similar to the
national trend for racial and ethnic minorities who bear a disproportionate disease burden.
(National Health Statistics Reports, 2019).
Managing diabetes is a challenge in the FQHC. Several factors have been reported in the
literature to be associated with inadequate management of diabetes including poor patient
compliance and engagement, insufficient medication and dietary adherence, patient problems
prioritizing diabetes self-management blood glucose monitoring, and self-care/wellness behavior
deficit (Settineri et al., 2019; Willaing et al., 2015). In the project FQHC patients experience
many of these barriers to effective management of diabetes and as a result often present to care
later in the disease process and with severe sequelae. Such patient level factors lead to more
complex systems-level factors such as higher utilization of emergency services, need for dialysis,
and diabetics requiring more lifesaving procedures. These conditions continue to create
recurrent financial burdens on the healthcare system.
A considerable challenge facing the FQHC project site is meeting quality indicators for
glucose control among its diabetic patients. The optimal quality indicator (or threshold) for a
patient with diabetes is a glycosylated hemoglobin of 7% or less. The FQHC’s predominantly
Latinx population struggles with long-term compliance. Often, providers manage a diabetic
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patient with an A1c greater than or equal to 10%, and it is common to identify patients with
A1c’s ≥ 14%. The high prevalence of uncontrolled diabetic patients within the FQHC led to the
administrative decision to support this QI pilot intervention.
Providers struggle at the FQHC project site with managing diabetes and common
comorbid conditions such as hypertension, hyperlipidemia, and obesity. Latinx patients often
follow traditional carbohydrate and calorie-dense diets of 1-2 large meals daily. Many patients
are overweight or obese. Managing diabetes in a population affected by chronic illness and
adverse social determinants of health is complex and demands focused attention on effective
patient self-management with frequent clinical follow-up.
Available Knowledge
A Preferred Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA)
guided literature search using Public/Publisher MEDLINE NLM journal articles database
(PubMed), Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Ovid
revealed strategies to optimize glucose control in patients with diabetes. Initial key search words
were diabetics AND blood glucose, education, and intervention which yielded thousands of
articles. The search was refined to include only studies in the past ten years, producing 285
relevant articles. After screening for relevance, ten studies were identified that examined
strategies to improve uncontrolled diabetes.
The Evidence Synthesis/Summary Table (Appendix A) provides a synthesis of the
studies selected for exploring effective strategies to optimize glucose control in diabetics. What
emerged from the review of this literature was the identification of three overarching types of
interventions which focused on education, nutrition, and glucose monitoring. A synthesis of
each of these interventions and their relevance to this project are discussed below.
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Education Intervention
Six studies concerned the impact of education on glucose control. The education-based
interventions were as follows: diabetes education by an expert (Deakin et al., 2006); physiciandirected diabetes education without medication change (Kim et al., 2017); peer-led education
(Philis-Tsimikas et al., 2011); group-based diabetes education (Rygg et al., 2011; Rickheim et
al., 2002); and diabetes self-management education by a community worker (Collinsworth et al.,
2013). Each of these studies reported improved A1c or glucose control that was associated with
the use of an education-based intervention. In addition, several studies also noted the association
of improved participant knowledge related to diabetes and enhanced self-management with this
intervention. (Philis-Tsimikas et al., 2011; Rygg et al., 2011; Deakin et al., 2006).
Although there is strong support in the literature for both individual and group educationbased interventions, both of which have demonstrated improved patient diabetes knowledge, it
was determined that a focus on an educationally-based intervention was not practical or realistic
at this time. The Covid-19 pandemic, which occurred during the time frame of this QI project,
added to already existing time constraints and challenges of hosting a QI intervention for this
complex patient population. Given the need to reduce the frequency of patients coming into and
out of the clinic as an ongoing safety measure during the pandemic, and given the highly varied
and complex educational needs of patients at the FQHC, it was determined that such a pilot
program would put an undue burden on the staff, and it would be difficult to quantify the results
of such an intervention over a short period of time.
Nutritional Intervention
Findings from research conducted on nutrition-based diabetes interventions strongly
supported the value of nutrition education in promoting improved patient knowledge and positive
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improvements in diabetic glucose control (Bowen et al.,2016). The importance of a nutritionbased intervention was further be exemplified in a study by McElfish et al., (2019), which
evaluated the effectiveness of culturally adjusted nutrition and diet planning as compared to a
standardized diabetic nutrition plan and the positive effects observed 6-12 months post
implementation of the culturally adjusted nutrition planning. Patients demonstrated significant
improvements in mean A1c when nutrition education had been tailored to consider culturally
specific components of the patient’s diet. However, similarly to the reasons for deciding not to
focus on an educationally-based diabetic intervention, given the constraints of the pandemic and
the complex and varied nutritional patterns of the patients at the project site, it was determined
that a focus on this intervention would be too ambitious to try to tackle at this time.
Glucose Monitoring
The third intervention concerned self-monitoring of blood glucose (SMBG). The studies
evaluated using an intervention that included glucose monitoring consistently demonstrated
improvements in glucose readings (Nadkarni, 2009; Polonsky et al., 2011; Strowing & Raskin,
1998). One study evaluated glycemic improvement when patients used glucometers with and
without computer-assisted analysis (Strowig & Raskin, 1998). This study highlights that there
can be tighter controlled glucose levels when providers can access downloadable blood glucose
readings compared to glycemic control solely by patient report. Another study evaluated
glycemic control in type 2 diabetes without injectable insulin use (Polonsky et al., 2011).
Another study assessed collaborative patient/provider diabetic s management implementation
plans in which patients returned home with a structured SMBG program (Nadkarni, 2009).
Patients in this study, with clearly planned diabetes interventions and goals demonstrated,
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continuous improvement in blood glucose control. Each of these studies demonstrated that
SMBG is an effective intervention for improving blood glucose control.
Based on the evidence reviewed, it was determined that the most feasible focus for the
pilot QI project would be the implementation of a home, self-monitoring (SMBG) glucose
monitoring intervention. Home blood glucose readings, when performed correctly, can be
objectively measured and therefore would be relatively easy to track for trends and to control for
reliability and validity of the data. It was also reasoned that SMBG might promote greater
patient engagement and self-efficacy with their diabetic care, as well as provide more potential
opportunities to work collaboratively with their healthcare workers regulating their glucose
status.
Though the focus of the intervention was SBMG during monthly follow-up visits,
participants would be provided with standard information about nutrition education, activity and
exercise.

Rationale
Diabetes is a chronic disease, and optimal outcomes require the patient, the provider, and
the system to work together. The Chronic Disease Model provides a framework that promotes
the participation of an informed, activated patient working in collaboration with informed,
activated health care members in the context of an accessible, affordable health center and
health-promoting community (The Chronic Disease Model: Improving Chronic Illness Care,
2021; Wagner, 2019).
Self-monitoring of blood glucose engages patients in their care and facilitates making
health promoting choices by prompting them to recognize abnormal glucose readings and to

9
correlate these readings with their food choices and activity patterns. Patient glucose logs also
serve to engage the clinician in ways that support shared decision-making about the treatment
plan.
Havelock’s Change Model guided the development, implementation, and evaluation of
this QI pilot project (Havelock, 1995). The model consists of six stages of change, from the
initial brainstorming and planning to the evaluation of the new process of change. The first step
involves “building a relationship” to assess the need for a change (glycemic and A1c control) in
the FQHC. The next step focuses on “diagnosing the problem.” At this stage, the agent driving
the change decides if the change is needed and welcomed. In this FQHC the change agents will
be the member of the project team consisting of the nurse practitioner and two medical assistants.
The change process may end at this point based on a decision to either move forward with a
process change or not.
As indicated earlier, it was decided to move forward with the improvement project based
on the high prevalence of uncontrolled diabetics. Next, it was necessary to “obtain resources for
change,” such as securing and making available blood glucose monitoring equipment for patient
use. It was anticipated that the greatest challenge with this QI initiative would be “establishing
and accepting the change” within the health centers microsystem. However, once the change
was initiated, then successfully established, and demonstrated success, it was expected that
accepting the change would become easier for all the staff, particularly the leadership. On the
other hand, it was also expected that the challenges of change will begin anew if the FQHC
decides to scale up the SMBG intervention throughout the organization. Acceptance will likely
be challenging because the employees will be predictably uncomfortable adopting new processes
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they are not familiar with. It was anticipated that generating a supportive environment for the
change would be difficult with the current intervention, but in the end, possible.
As the SMBG pathway gains consistent use with the pilot team, it will become essential
to maintain weekly oversight, ensuring the transition remains a new part of the pilot team’s
clinical workflow. It was crucial to utilize open communication, while also being responsive to
staff questions and challenges, and effectively redirect staff when diverting from the newly
established clinical pathway. This process would require detailed pre-program planning,
education, and reinforcement of multidisciplinary support systems within the FQHC throughout
the pilot QI project.
According to Havelock’s Theory of Change, the change agent will know they can be
separated from the improvement project when staff has fully implemented the change as the
“new normal” (Havelock’s Theory of Change: 6 Easy Steps to Change). To accomplish this, the
project leader would need to design a structured “maintenance plan” to establish a sustainable
program. For the program to remain intact and sustainable, it will require the following: 1.
Evidence of successful outcomes supporting glycemic control (i.e., improved glucose levels and
A1c). 2. Staff and leadership to continue the ongoing use of the focused SMBG intervention
with all diabetic patients throughout the organization.
Specific Aims
The purpose of this QI project was to improve patient self-management behavior and
glucose control in patients with uncontrolled diabetes (A1c ≥ 10%). The overarching aim was
the implementation of a multidisciplinary clinical pathway to promote self-monitoring of blood
glucose in patients with uncontrolled DM2 (A1c ≥ 10%) within one primary care provider’s
patient panel in the FQHC. The specific aims of this QI project are:
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•

Convene a multidisciplinary team to foster the use of an SMBG clinical
pathway to improve uncontrolled diabetic A1c’s.

•

Identify and enroll diabetic patients with an A1c ≥ 10% or POC
random/fasting blood glucose ≥ 200 mg/dl, from one pilot providers panel in
the SMGB program.

•

Integrate the standardized SMBG pathway into each care encounter.

•

Diabetic patients will engage in active participation with daily SMBG levels
for three months and increase self-efficacy and self-care behaviors related to
SMBG.

•

Patients will achieve reductions in A1c.

•

Patients and staff will demonstrate confidence with the SMBG pathway.

Methods
Context
The proposed quality improvement project was implemented within an FQHC, serving
disadvantaged and underserved patients. Since 1981, the FQHC has played a significant role in
helping to fill the gap in health care access to quality health care services for Los Angeles
residents. This FQHC is designated a medical home and its primary mission is addressing health
care disparities in a competent and culturally conscious manner. The health center gained FQHC
330 clinic status in 2002, thus demonstrating adherence to quality metrics set by the federal
government when providing and reporting quality and comprehensive primary health care
services. The site where this QI project was implemented is the largest of 11 South LA health
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centers within the organization and, offers primary adult care, dental care, chiropractic
management, behavioral health services, prenatal and pediatric care.
The care delivered in this center is fast paced, with 12-20 providers (physicians and
advanced practice providers), each treating an average of 20-25 complex patients daily. Meeting
the demand for these high patient volumes comes with the challenge of ensuring high-quality,
patient-centered care in the abbreviated time provided for each visit. Organizational structure in
the health center consists of a Board of Directors, Administrative Senior Leadership, and patient
care providers with the assistance of all other support staff. All licensed health care providers
report to the Medical Director, who oversees 11 care delivery sites. In addition, each health care
provider is part of a patient care team consisting of an MD/DO, several Advanced Practice
Providers (APPs), a licensed vocational nurse (LVN), and several medical assistants. To provide
the best service at the point of delivery during the QI project, clinical staff needed to be
knowledgeable, comfortable with, and proficient in using the proposed diabetes management
pathway. An external mapping tool was used (Appendix B) to understand the core systems
components of providing high-quality patient care for the uncontrolled diabetic patient in this
pilot FQHC.
Most office visits for diabetes care are conducted face-to-face with a licensed health care
provider, medical office assistants, clinical pharmacists/technicians, laboratory professionals,
front desk/administrative staff, and specialty service providers such as podiatrists and dietitians.
Diabetic patients typically present to the clinic with complex and wide-ranging needs. As noted
previously, most patients do not attain the desired A1c goal of 7% and many exceed 10%.
A Cause and Effect “Fishbone” diagram (Appendix C) was used to illustrate the factors
associated with uncontrolled diabetes in the patients who received care at the health center. The
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five outstanding categories used to organize and differentiate the varying contributors were:
patient, provider, community/social determinants of health, and resources within the community.
Using each of these categories helped to identify significant issues facing patients treated in the
FQHC. As complex and involved as these may be, they helped highlight functional areas for
improvement with the scope of this QI project.
Self- monitoring of blood glucose (SMBG) engages patients directly into the process of
self-managing their diabetes and promotes other healthy behaviors which can influence disease
process. Early identification and targeted diabetes self-management behaviors can promote
diabetes glycemic control. With improved SMBG behaviors, patients can begin to control their
chronic disease better.
In South Central Los Angeles, adverse social determinants of health are endemic and
difficult to modify, however increased engagement in self-care has been shown to improve
glucose control despite the challenges. Patient self-monitoring of blood glucose aids patients in
understanding the many factors that influence glycemic control and what daily events cause
glycemic spikes and lows. When a patient presents a glucose log to the pilot provider, the
provider is better able to understand the need for individualized changes in a diabetic patient’s
treatment plan. When both patient and provider are activated and engaged in tandem, long-term
diabetes control outcome improvement becomes more likely. When patients return to the clinic
with completed blood glucose logs, this helps to focus, simplify, and optimize the provider’s
time, allowing for a more effective visit. The self-monitoring program brings all patients closer
to necessary resources by providing each patient with a free or subsidized glucometer, testing
strips, and lancets through discounted pricing in the organization’s internal dispensary
(pharmacy).
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Successfully implementing a new practice change in any organization can be challenging.
A Force Field Analysis helped to illustrate the factors which could facilitate and constrain
successful implementation (Appendix D). Capitalizing on the organization’s strengths and
driving forces including the desire of clinicians and leadership to meet quality metrics for A1c
control was important to the success of the project. The restraining forces proved to be
challenging. Clinician time constraints and incentivization for providers to see higher patient
volume, make added time demands and additional or newer tasks difficult for an already stressed
team made streamlining the pathway critical.
Intervention
The Self-Monitoring Blood Glucose (SMBG) pathway was implemented in one
Figure 1: SMBG Clinical Pathway

provider panel in primary care at the FQHC from August
2021 through
Standard Care:

Diabetic
patient
presenting
to FQHC.

On Intake:
Obtain Vitals, A1c,
R/FBG, UA
(POCT)

No

Is (POCT)
A1c ≥ 10%?

Is (POCT) A1c:
Below 10% but
greater than 6.5 ?

Yes

Yes

Provide Standard
Care & F/U in
1-3 mos. for
repeat evaluation
and continued care..

No

Will patient
agree to
participate in the
SMBG daily log
w/ standard
care?

Explain Focused BG
Monitoring Log.

Diabetic
patient
presenting
to FQHC.

Discuss initiating or
continuing
DM2, Focused SelfMonitoring Blood
Glucose (SMBG) log
with patient.

Yes

included two

No

one nurse
practitioner.

Yes

The SMBG
No

Is (POCT)
A1c ≥ 10%?

The pilot team

assistants and

Will patient
agree to
participate in the
SMBG daily log
w/ standard
care?

Discuss initiating or
continuing
DM2, Focused SelfMonitoring Blood
Glucose (SMBG) log
with patient..

On Intake:
Obtain Vitals, A1c,
R/FBG, UA
(POCT)

January 2022.

medical

Yes

Patient teach back to
provider for
understanding.
Provide BG Logs.
Rx. A Glucometer
& supplies.
Q&A, Discharge & F/U
in 1 month.

Refer to Dietician,
Provide brief DM2
education (activity,
portion control, &
medication use),
Review all care
Guidelines, Order
outstanding items.
Continue Meds or
Adjust Regimen.
Wrap-Up w/ Q&A.
Discharge Plan &
F/U in 1-3 months.

Is (POCT) A1c:
below 10% but
greater than 6.5 ?

Yes

clinical pathway
as shown in

Figure 1 was initiated when any patient with diabetes presented for a non-urgent medical visit
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(see also Appendix E). Once accepting participation and enrolled in the self-monitoring
program, patients were asked to follow up monthly with the pilot provider for continued support
and participation in the SMBG intervention. The SMBG pathway is illustrated in Figure 1. As
noted in the diagram, the algorithm begins with a diabetic patient presenting for care. Once the
patient checked in, they were called from the waiting room and brought to the clinical back
office. The medical assistant (MA) obtained a POC finger stick for random/fasting blood
glucose and/or a glycosylated hemoglobin A1c (if unavailable within the prior 90-days). All
program participants were screened and evaluated for a current A1c measurement within 90 days
by reviewing the patients’ medical records in the organizations electronic medical record (EMR).
Each of the POC results are available quickly (15-30 seconds for random/fasting glucose and
four minutes for A1c), allowing the pilot provider to make informed clinical decisions in realtime based on the current degree of diabetes control. Diabetic patients with an A1c <10% but ≥
7% received standard care which consisted of a referral to the in-house dietitian and a providerdelivered focused in-office diabetes reinforcement education session. The focused education
included individual goal setting, and general information about portion control, medication
issues, and movement/activity promotion. The pilot provider reviewed individual patient care
guidelines and ordered any outstanding health maintenance items. The pilot provider had an
opportunity to review treatment plans and adjust or make care plan changes at that time. Once
the pilot provider completed the clinical decision-making, the patients were then sent home with
a plan for follow-up in 3 months.
If a diabetic patient presented for care and the A1c was ≥ 10% or the POC glucose ≥200
mg/dl, the pilot provider offered the SMBG intervention. If patients agreed to enrollment and
participation the patient received standard care in addition to expanded education with teach
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back regarding how to check blood glucose and use monitoring equipment. Glucose log
management, and diet/activity reminders were provided. Patients were educated to understand
how elevated or low glucose readings correlated with diet or activity/non-activity. The pilot
provider explained self-managing if values were too high/low. The patient would then be
scheduled for a one-month follow-up. If a diabetic patient returned before the appropriate
monthly interval the pilot provider used random or fasting glucose measurements. POC glucose
levels ≥ 200 mg/dl indicated the patient should participate in the SMBG program. All patients
with an A1c ≥10% or POC glucose ≥200 mg/dl were given the opportunity to participate in daily
SMBG. If a patient opted out, they were offered the option at each following visit. Those who
declined received standard care as described above and were scheduled for three month follow
up.
For all patients enrolled in SMBG, a daily blood glucose log was provided, and the
patient was furnished a prescription to a retail pharmacy or the FQHC dispensary to access a free
or subsidized glucometer, test strips, and lancets. The pilot team and patient ended each
encounter with the opportunity for questions, concerns, or further clarification. The encounter
was completed by one of the medical assistants (MAs) and a follow up appointment was
scheduled in one month for continued clinical care and review of adherence and participation.
At each following visit the provider reviewed the patient’s home glucose readings and provided
feedback. This practice was an essential principle of the pathway and a critical tenet in
supporting a patient to meet their diabetes goals. Every 90 days (3 months), participants in the
SMBG program had an A1c completed.

Implementation of the Intervention
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Prior to beginning the SMBG program, the project coordinator obtained leadership
support and buy in. The proposed intervention and clinical pathway were reviewed with both the
organization’s Medical and Quality Improvement Directors. Once this was completed, all pilot
team members had a chance to review the program outline and SMBG clinical pathway as well
as pose any clarifying questions. The pilot provider conducted a short huddle-style education
session to each of the team members at the beginning of each shift for the first couple of weeks,
and then weekly thereafter. Copies of the SMBG pathway were provided to each team member
both electronically by email as well as by posting a hard copy of the SMBG pathway in each
exam room and in the patient POC lab.
Evaluation of the Intervention
Using the Plan-Do-Study-Act (PDSA) methodology, the pilot team had the option for
continuously evaluating the SMBG intervention, propose as-needed modifications, and then
retest with the new improvements in place (Appendix F).
Measures
Specific Aim # 1– Convene a multidisciplinary team to foster the use of an SMBG
clinical pathway to improve uncontrolled diabetic A1c’s.
Attainment of this aim was defined as the following:
1. Identification of two medical assistants and a nurse practitioner to pilot the SMBG
intervention.
2. Having senior and medical leadership approval and support of the QI project.
3. Getting consensus of the organizational leadership and clinical team on the SMBG
pathway.
4. Training the staff on the pathway.
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5. Documentation of attendance with the brief weekly, focused training sessions via sign
in sheet. Each of these defined and helped to determine if this aim had been met.
Specific Aim # 2 – Identify and enroll diabetic patients with an A1c ≥ 10% or POC
random/fasting blood glucose ≥ 200 mg/dl, from one pilot providers panel in the SMGB
program.

Daily patient schedules for the provider were reviewed to identify eligible patients
(diagnosis diabetes). Each diabetic patient identified on the panel was screened with for A1c or
F/RBG. All patients with an A1c ≥ 10% or F/RBG ≥ 200 were offered participation in the
SMBG program.
The threshold set was to enroll 75% of eligible diabetic patients with an A1c ≥10% that
would agree to participate. The number of patients who elected to participate in the SMBG
program was tracked in relation to the number of patients who were eligible for the pathway.
Specific Aim # 3: Integrate the standardized SMBG pathway into each care encounter.
Evidence of the use of the SMBG pathway with each diabetic patient care encounter was
operationalized as notations in the patient’s medical records. Each patient follow-up visit in the
EMR was reviewed to determine if the participants had met all prescribed care measures.
Specific Aim # 4: Diabetic patients will engage in active participation with daily SMBG
levels for three months and increase self-efficacy and self-care behaviors related to SMBG.
Engagement of active participation was defined as recording a minimum of one blood
glucose recording over a minimum of four days per week and attending the three follow-up
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visits. All related patient activity was recorded on the tracking form with each follow-up visit.
The goal was for 75% of participants to meet the criteria for engagement in active participation.
Self-care behaviors were defined as the patient’s successful return to the follow-up
appointments with daily glucose logs completed and the ability to describe any challenges they
had with home monitoring over the past month.
Specific Aim # 5: Patients will achieve reductions in A1c.
The overall reduction in A1c was measured by comparing POC A1c pre-participation in
the SMBG pathway to the 3-month, end-of-program POC A1c. The goal was that 80% of
participants would demonstrate a 2 -point decrease from baseline in A1c at the end of the
intervention. Individual-level changes were evaluated to determine the proportion of patients
who achieved the goal of reducing A1c by 2 points from baseline to post intervention.
Specific Aim # 6: Patients and staff will demonstrate confidence with the SMBG
pathway.
At the end of the intervention patients were asked to provide feedback on participation in
the SMBG intervention and to self-report their experience with daily blood glucose checks and
maintaining a glucose log. Each of the 13 patients completing the 3 months of follow-up had a
monthly blood glucose log scanned into the EMR. At least 90% of participants were expected to
have completed an anonymous, short 7-8 question pre and post survey. A patient survey was
given at initiation and completion of the QI intervention. The survey assesses the overall rate,
frequency, and quality of blood glucose monitoring and perceived participation in their diabetic
self-care. Patient engagement in self-care was defined and measured as the patient’s ability to
demonstrate improved chronic disease management behaviors. The goal was that 80% would

20
self-report healthy self-care behaviors such as keeping a continued SMBG log, eating more
nutritious foods, improving portion control, making lifestyle adjustments based on glucose
spikes, and engaging in regular exercise or movement activities. The frequency of positive
health behaviors pre- and post-intervention were calculated in proportion to the number of
participants that completed the SMBG program. At the individual level, pre/post change were
calculated and scored “yes” if the patient moved from “no” to “yes” in that category. The
proportion of “yes” indicated a positive change from pre to post in relation to the total number of
participants.
Staff self-reported confidence in using the SMBG pathway was measured by means of a
survey. The survey was constructed by the project lead and consisted of nine questions
demonstrating the interest in the continued use of the SMBG clinical pathway and promoting its
sustainability. Seven questions evaluated the staff’s degree of comfort on a Likert scale (1-5)
with 5 correlating with “strongly agree” and 1 correlating with “strongly disagree”. For each
survey question the mean Likert score was calculated (see Table:1). Staff surveys consisted of
questions guided by Havelock’s Change Theory. The goal was for 80% of staff to be satisfied
with the clinical pathway by observing either a 4 (Agree) or 5 (Strongly Agree) mean average
per survey question, indicating success and staff satisfaction.
The surveys were designed to determine if the organizational driving forces facilitated
change by encouraging employees to utilize the SMBG program at every opportunity. Staff
surveys were completed individually and then reviewed by the pilot provider. Each member of
the team was given an opportunity to share successes and challenges in a private group huddle as
well as to offer suggestions for ways to improve the intervention.
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Analysis
Descriptive statistics including frequency, proportion, aggregate means, change, and
percent improvement were used to assess attainment of the stated goals. Qualitative responses
were reviewed, and themes identified for both patients and staff to share challenges, strengths,
frustrations, and recommendations for any changes they thought were necessary.

Ethical Considerations
The quality improvement project had no conflicting ethical considerations. The
intervention was evidence-based and was integrated into participants’ usual care. Patients were
included in shared decision-making with respect to determining the best treatment plan for them.
At the project FQHC, the Medical Director and Quality Improvement Department along
with Site Champion reviewed the improvement project and proposal for use within the
organization. There was no formal process outside of presenting the proposal for review to the
Medical Director and Quality Improvement Department. Both the Medical Director and QI
Department agreed that the quality improvement project was warranted, appropriate, feasible,
and well suited to drive improvement in patient care within the FQHC.
The University of Massachusetts Boston Clinical Quality Checklist was completed and
demonstrated that the project was a quality improvement project and did not involve human
subjects (Appendix G). The project or innovation proposed met the criteria for quality
improvement and not the definition of human subject’s research because it was not designed to
produce generalizable findings. Rather, it was designed to provide immediate and continuous
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improvement feedback in the local setting in which the project was carried out. The University
of Massachusetts Boston IRB has determined that quality improvement projects do not need to
be reviewed by the IRB.
Results
The improvement project was carried out between August 2021 through January Prior to
the project implementation, the SMBG clinical pathway was developed and then approved by
medical leadership, the director of quality, and finally the clinical staff on the participating pilot
team. Team members were trained in the proper use of the SMBG pathway. Potential patients
were drawn from one provider’s daily panel of patients. As diabetic patients presented for care,
each day they were evaluated for inclusion in the clinical pathway. The pilot team included two
medical assistants and a nurse practitioner. The SMBG clinical pathway was initiated when any
patient with diabetes presented for a non-urgent medical visit (Appendix E).
The SMBG clinical pathway was made readily available for team use. This allowed the
medical assistants to effectively screen the appropriate patients prior to the nurse practitioner
evaluating them. Patients were evaluated for inclusion in the program; and were screened with
either an A1c or F/RBS reading at the time of the office visit. All patients with an A1c ≥10 or
F/RBG ≥200 were offered the opportunity to participate with the daily SMBG intervention.
Forty patients were identified who met the A1c threshold for participation. The number of
patients who elected to participate in the SMBG program was tracked in relation to the number
of patients who were eligible for the pathway.
Over the implementation period, a total of 40 patients were identified and deemed
appropriate to participate. Individuals with diabetes and who had a POC A1c equal to or greater
than 10% (range 10% to 14%) were given the option to electively participate in daily SMBG
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(n=40). Of the 40 patients identified as able to participate 18 (45%) opted into the SMBG
intervention on the first visit. The mean age for participants was 45 years, they were
predominantly men (62%; n=8), all participants identified as Latinx ethnicity (100%, n=13). All
participants were either eligible for Medi-Cal coverage (67%, n=9) or were uninsured (33%,
n=4) with the option to utilize a reduced sliding fee scale, which is a proxy for low
socioeconomic status and educational attainment. Of the 18 who agreed to participate in the
SMBG pathway, 13 patients followed up for continued participation at the first, second and third
month follow up visits. Each of these 13 patients presented to each follow up visit with
completed blood glucose logs for the full length of the 3-month intervention. This represents a
completion rate of 72%. The initial goal set for enrollment and participation was 75%, and
possibly in future change cycles, the goal can more realistically be lowered to 40-50%
enrollment and participation. A participation rate of 45% is comparable to findings in the
literature review of programs utilizing blood glucose measurement initiatives (Dailey, 2007;
Harashima et al., 2016.)
The reasons patients gave for declining participation varied. Some patients were not
interested in participating in checking glucose levels daily as they did not feel ambitious about
daily punctures to check blood glucose. Some patients were more interested in medication
changes and a few patients insisted they could manage their diabetes primarily with diet and felt
as if they did not need to check their blood glucose daily. Some patients denied the need for
glucose checking or medication use.

Convene a Multidisciplinary Team
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Before initiation of the SMBG QI project, medical assistants were identified who were
interested to improve uncontrolled diabetes and comfortable with diabetic care. All three staff
on the pilot team remained dedicated to using the SMBG pathway. Each team member utilized
the clinical pathway without difficulty, specifically as the SMBG pathway became a uniform part
of patient intake. The pilot provider regularly reminded team members of the pathway’s
importance as well as directing attention to patient improvements. As patients saw improvement
in glucose numbers recorded on the logs, team members acknowledged this and helped provide
patient encouragement. Patient recognition of glucose improvement helped promote staff
commitment to the intervention. In line with what the Chronic Disease Model purports, engaged
patients and providers generate improved outcomes.
Patient Identification, Enrollment, and Integration of the SMBG Pathway
The initial education sessions provided to each staff member on the team helped to
promote identification and enrollment as the medical assistants could clearly follow the pathway
algorithm. Each staff member had access to both electronic and paper versions of the SMBG
pathway. The pathway was also posted on a bulletin board located in each of two exam rooms as
well as within the intake lab where POC testing can be performed. All team members had access
to both POC glucose measurement devices and supplies. Each diabetic patient was screened
with either an A1c or R/FBS at each visit. Team members were consistently able to obtain the
appropriate glucose reading for each participating patient. As Havelock’s Change Theory
explains, promoting autonomy and empowerment for all team members to initiate the pathway
likely played a role in successful identification and then progressive enrollment.

Patient Engagement, Self-Efficacy and Diabetes Self-Care
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Participants who completed the program (n=13) were asked to reflect on their self-care
over the past three months to assess progress toward goals and to participate in shared decision
making about future goals (Appendix H). Patients self-rated their health behaviors related to
engagement, self-efficacy, and diabetes knowledge as noted on Table 1. The survey questions
were designed to allow the patient to share the perception of their own health related self-care
behaviors. Participants demonstrated improvement in self-care behaviors by adhering to the use
of daily SMBG logs. Each of the 13 participants who completed all 3 months of follow-up also
returned to the clinic with completed logs. At the end of the 3 months of follow-up, patients
reported were confident about how to access and utilize tools, health care equipment, and
appointments when necessary.
Table 1: Patient Self-Reported Health Behaviors

(Scale is 1 to 5 with 5 indicating high agreement with the statement.)
Q#

Patient Post QI Implementation Survey: Self-Reported Health Behaviors

Mean
Score
4.2

Q1

How confident are you that you know when to see the doctor based on changes
with your diabetes?

Q2

I was able to obtain a blood glucose monitor, test strips and lancets.

4.2

Q3

I was able to check my blood glucose every day and record the results in my
home blood glucose log.

3.9

Q4

Knowing my daily blood glucose results helped me to know when to see my
health care provider based on changes in blood glucose levels.

3.7

Q5

I am more confident that I understand what to do at home, when my blood
glucose levels are abnormal, as compared to before I started measuring my
blood glucose daily.

3.8

Q6

I feel as if my diabetes has improved over the past 3 months.

3.9

Q7

Overall, I was satisfied with daily blood glucose monitoring.

3.9
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Improvement in A1c
Improvement in A1c was calculated for those patients who had POC A1c
Pre/Post A1c Change (N=13)

2
2
15% 16%

2
15%

7
54%

Decrease in A1c < 2
pt
Decrease in A1c 2
pt. or >
No change in A1c
Increase in A1c

measured at baseline and 3 months
(n=13). Of these 13 patients, 54% (n=7)
achieved the goal pre/post decrease in A1c
by 2 or more points, while 69% (n=9)
achieved at least some decrease in A1c.
(Figure 2).

Figure 2: Pre/Post A1c

Staff Satisfaction
At the conclusion of the project staff completed a survey assessing the feasibility and
value added of the pathway. Staff rated the pathway positively, responding that they agreed
(mean response 4) or strongly agreed (mean response 5) with the majority of questions asked (se
also Appendix I).

27
Q#

Staff Post QI Implementation Survey & “Round Table Huddle”

Q1

The diabetes SMBG program was realistic, practical, and easy to work with and
fit within the 15-minute office visit.
It was easy to identify an uncontrolled diabetic patient using the SMBG Clinical
Pathway.
Once an uncontrolled diabetic patient had been identified, I felt empowered to
suggest the patient participate in daily blood glucose monitoring.
Checking patient’s POCT blood glucose or A1c, and then reporting and
recording the results in the EMR was clear and concise.
Patients typically returned to the office with their home blood glucose logs
when asked.
When patients monitor and record their blood glucose daily, this practice adds
value to the patient care experience and promotes diabetic glucose control.
In the future, I am confident that I could apply the clinical pathway to all
uncontrolled diabetic patients and could continue to identify and enroll
uncontrolled diabetics if every given the chance to.

Q2
Q3
Q4
Q5
Q6
Q7

Mean
Score
4
4
4
5
3
4
4

Table 2: Staff Satisfaction

Of note, the one area they ranked lower (3; neither agree nor disagree), pertained to the
staff members assessment of participants engagement in using the SMBG logs at each visit. The
project lead followed up with the team to get more insights into this issue. Staff suggested that it
became obvious, there was about a 50/50 chance patients would return to the office with blood
glucose logs, specifically at the first 1 month follow up visit. Common responses from patients
when asked about the blood glucose logs would be a simple, “I forgot it at home”. Some patients
would flash pictures on their phones of their glucose meters with intermittent glucose numbers,
however, did not complete the requirements for daily monitoring. Some patients did not present
with blood glucose logs; however, they did have positive reflections in the blood glucose
readings. Some patients lost the log and would request a new one each visit. The consistent
return of the blood glucose logs was essentially “hit or miss”.
Discussion
Summary
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The overall outcomes for this QI intervention in the FQHC were clinically significant in a
hard-to-reach and challenging-to-treat population. The pilot team reported the SMBG clinical
pathway was useful in helping their diabetic patients meet their blood glucose goals. Initially,
the uptake and acceptance of the new process change was a challenge as expected, however,
having team huddles to discuss successes and challenges helped to fix this issue. Each of the
pilot team medical assistants understood the rationale behind the need for an organized pathway
to help patients manage uncontrolled diabetes. The three staff members who participated in the
process (an APN and two medical assistants) reported a high degree of satisfaction with the
pathway in relation to feasibility, ease of use and value added to care (Table 1), which is
important to sustainability of the initiative. One of the important outcomes that links closely to
the first specific aim relating to the uptake and use of the new process change and
implementation of the SMBG, is that the team must be on board and understand why they are
being asked to make changes from the baseline. Havelocks Change Theory introduces the
importance of “buy-in” and “team collaboration” and the need for these attributes became
obvious early in the change process. In any team, all team members have a role, and each role is
interdependent on the others. Once the entire pilot team was on board with understanding the
intervention and why it was an important process change, the uptake and acceptance as well as
eagerness and willingness to utilize the SMBG clinical pathway began to take off.
Once the SMBG clinical pathway was being utilized on a regular basis, identifying
patients who are appropriate to be offered the SMBG and monthly follow-up became second
nature. An unintended positive consequence of integrating the medical assistants into the SMBG
pathway was that the pilot medical assistants developed a degree of empowerment and comfort
with self-identifying patients they thought might be eligible for participation. Within this
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specific FQHC, support staff reported that they do not always feel autonomous, and the overall
culture of the clinic as it applies to medical assistants is that of task orientation. Early in the
implementation process a discussion was had among the pilot team, where the medical assistants
expressed hesitancy to make suggestions to providers. This was important to optimizing the
team working together to implement the SMBH pathway and which ultimately benefited
patients. As we continue to move closer to value based care it will be important for
improvement teams and health care leaders to promote a comfortable environment where all
employees feel empowered to be agents and activist for change.
Working in a clinic that treats underserved and socio-economically challenged
individuals from the area, it comes as no surprise that it can be difficult to promote engagement
in care and adherence to treatment plans. Overall, the high rate of participation in completing the
glucose logs and attending the follow-up sessions, as well as the reductions in A1c noted was
impressive considering the challenges inherent in treating this high-risk demographic. One of
the most rewarding parts of seeing the patients improve, was watching them slowly start to get
behind developing new healthy habits each month. This QI intervention allowed the pilot team
to bring nine patients closer to understanding how chronic diseases, such as diabetes, can have an
adverse effect on you if you let them, but also can be managed with conscious effort and
persistence.
There were some unexpected challenges to this QI project. First, although the use of the
SMBG is efficient in monitoring the glycemic levels, the intervention participants were fewer
than anticipated. Initially, 18 participants enrolled in the pathway, but five were lost to care, and
the total number of participants that completed the program was 13. It is possible that some of
the participants did not continue with the program because of the cost associated with supplies.
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If the project is continued and scaled-up, access to affordable testing materials would be
beneficial.
Manually tracking blood glucose levels at home was also reported to be a challenge,
specifically having to keep track of a glucose logbook, and remembering to carry it with you
were a problem. Future initiatives might consider looking at more convenient ways of tracking
glucose levels such as, evaluating electronic or mobile based glucose logs. It is also possible that
patients could not afford to present to the office monthly. Having a language-concordant staff
member call patients in between visits, such as “diabetes wellness checks” or considering
telehealth visits for two of the three monthly follow-up visits might reduce the burden of having
to present to the office monthly. Working with a predominantly only Spanish speaking
demographic with limited health care literacy makes utilizing complex or multi-step technology
or processes challenging, therefore a focus on convenience and ease would be important.
Patients that enrolled and completed the SMBG patients tended to respond favorably to
the intervention. The fact that 72% of patients returned to the office monthly demonstrates a
participant’s willingness to be engaged in their own wellness. Showing up for visits is a positive
self-management behavior. Patients tended to have a more positive outlook on glucose control
as they started to understand that not only were they invested in their health, but that the clinical
team was equally invested in their success. The Chronic Disease Model supports that engaged
patients and staff promote optimized health care behaviors when it comes to managing chronic
conditions such as diabetes.
This project has helped to highlight that SMBG is an important strategy to promote
glycemic control in diabetes. Of note, A1c levels for the patients that completed the intervention
declined, with only 15% of patients having no change in A1c. Thus, in this setting, daily SMBG
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and monthly check-in has been an important strategy to promote glycemic control in patients
with uncontrolled diabetes.
Participants who indicated healthy behaviors on the survey at the end of the program
tended to have improved levels of understanding about how to obtain monitoring supplies and
when to see the doctor if glucose was not controlled. When asked to complete a post-survey,
participants responded favorably (mean score 4.2) in relation to “How confident are you that you
know when to see the doctor based on changes with your diabetes?” and “I was able to obtain a
blood glucose monitor, test strips and lancets.”. This is critical for patients seeking to manage
their blood glucose levels at home with SMBG logs as it demonstrated that each patient
understands how to obtain the necessary equipment as well as knowing when to return to the
office if glucose is not well managed at home.
In the future an education-based improvement intervention may potentially demonstrate
improved diabetic knowledge. Based on a review of the literature, education-based interventions
whether individual or group have consistently demonstrated improved patient diabetes
knowledge. (Bowen et al., 2016; Collinsworth et al., 2013).
The literature reports that the use of SMBG has both positive and negative impacts on the
quality of life of diabetic patients as well as well-being and satisfaction. Positive outcomes
include improved understanding of the patient’s performance in managing the disease. The
medical staff can understand the necessary changes in terms of medication, physical exercise
regime, and the diet necessary to help manage the glycemic levels and prevent
hyper/hypoglycemia. These management practices improve the patients’ quality of life and their
ability to live a healthy life. Anecdotal feedback from participants and staff endorsed these
positive effects from the SMBG pathway.
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Negative consequences of SMBG for patients with diabetes, as reported by Harashima et
al. (2016), include higher distress, worry, and depressive symptoms. Worsening perceptions of
their health when included in the SMBG was reported by Wada et al (2020. Our experience was
similar as the four participants who experienced an increase or no change in A1c levels
expressed frustration with the pathway. When asking patients to perform glucose checks it is
important to remain realistic and practical as to how often they will be asked to check their blood
glucose. Based on these concerns, the criteria for meeting the projects definition of daily SMBG
was reduced to four glucose checks per week to allow for some human error and flexibility in
how often patients were checking their blood glucose. If the expectations are too high, patients
may avoid checking blood glucose levels altogether. For the patients that were able to
successfully check blood glucose a minimum of four times per week, this seems to be a realistic
request, which perhaps allowed each of the 13 participants to succeed with daily monitoring.
In future initiatives designed to help patients manage glucose levels, it would be helpful
to consider an option where patients can obtain a continuous monitor and view glucose levels on
an e-platform. Recently the FQHC obtained a grant for some patients to receive a continuous
glucose monitoring device. This presents an important opportunity to optimize the pathway.
SMBG can be related to increased costs incurred by the diabetic patient related to the
supplies necessary. Patients need access to test strips, lancets, and a glucose monitoring device.
Not all patients have medical insurance and not all insurers cover these supplies. Every strip can
be used only once; hence increasing the number of times a patient checks blood glucose in a day
increases the cost of overall diabetes management. Because many patients cared for in this
FQHC experience socioeconomic challenges, it is important that future QI interventions consider
the cost associated with a SMBG pathway.
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Conclusion
In conclusion, management of the glycemic level for effective diabetes management
requires the participation of the patients and the medical staff. Proper management ensures the
right steps are taken to enhance the patients’ care and overall health. For providers, measuring
A1c is a simple blood tests used to determine the blood sugar levels in the patient over three
months. It is important because it helps a clinician understand whether the patient is responding
to treatment, and it allows the provider to coach the patient. For patients, measuring random
glucose at home helps the patient stay on track with healthy diabetes behaviors. Patients who
maintained proper follow-up and adhered to the guidelines for SMBG improved their A1c, thus,
it is important for patients to continue with this patient-driven strategy to ensure ongoing
diabetes control. Also of note, implementation of the SMBG pathway was shown to increase
satisfaction in the team members, particularly the medical assistants. Overall, implementation of
the SMBG pathway provided efficient, supportive care that resulted in improved glucose control
in this challenging-to-treat population and demonstrated the utility of effective collaboration
between the patients and the healthcare staff.
Recommendations
For future diabetic glucose management interventions and cycle changes in this FQHC it
would be ideal to have all providers and clinic staff implementing and utilizing the SMBG
pathway. It would be beneficial for all staff to be educated and trained on the proper use of the
SMBG pathway as an organization wide initiative. Organizational wide implementation of the
pathway including all providers would promote continuity of care and a robust approach to
diabetes care at the FQHC. In the future it would also be ideal to allow patients to utilize a
phone or tele-health option for follow-up to decrease the burden of in-person appearances every
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month. It is well known that patients served in this area can rarely sacrifice a day of work to
attend appointments without fear of lost income. For future improvement initiatives, obtaining
no cost glucometers for all participants could help to alleviate any burdens associated with cost
for supplies. In this FQHC with a high prevalence of patients with uncontrolled diabetes and the
common comorbid conditions, it would be ideal to have a diabetes educator or diabetes
counselor. This could help patients receive more intense education sessions which could be
tailored to them, while also participating in daily SMBG.
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Appendix A - Table 1: Evidence Synthesis/Summary Table
INTERVENTION

# OF
STUDIES
INTERVENTION #1: EDUCATION
A. EFFECTIVENESS OF A
COMMUNITY HEALTH
WORKER-LED DIABETES
SELF-MANAGEMENT
EDUCATION PROGRAM.
B. STRUCTURED
PATIENT EDUCATION:
DIABETES X-PERT
PROGRAM.

Collinsworth
et al. (2013)

C. PHYSICIAN-DIRECTED
DM EDUCATION
WITHOUT MEDICATION
CHANGE.

Kim et al.
(2017)

D. PEER-LED DIABETES
EDUCATION PROGRAMS
IN HIGH-RISK MEXICAN
AMERICANS IMPROVE
GLYCEMIC CONTROL
COMPARED TO
STANDARD CARE.
E. ASSESSMENT OF
GROUP VS. INDIVIDUAL
DM EDUCATION.

Tsimikas et
al. (2011)

F. EFFICACY OF
ONGOING GROUPBASED DM SELFMANAGEMENT

Rygg et al.
(2011)

Deakin et al.
(2006)

Rickheim et
al. (2002)

DESCRIPTION OF SAMPLE

Mixed-method, longitudinal study. N: 806 patients (18 yrs.
+). All enrolled in first 18 mos. & un or underinsured.
Target population - Latinos/Hispanic (70%). Study ran
9/2009 - 3/2011. 60% female. Aged 40-59 yrs. old (64%).
Program completion: 1.1yrs on average.
RCT. Use of the X-PERT Program: Empowerment &
discovery learning. Equal numbers per arm. Participants
blinded. Outcome evaluation by nurse & health care
assistant blinded to treatment assignment. Adults with DM2.
N= 314. Men = 52%. Mean age at 1st dx. DM2 = 54 y.o.
Mean age at recruitment = 61.5 y.o. Median duration of DM
dx. = 5 years. Housebound & reduced cognitive ability,
excluded. N: 195 participants (83%) having left full-time
education at the age of 16 y.o. 83 participants (26%)
treated with diet alone. 178 participants (57%) treated with
oral DM2 agents. 53 participants (17%) treated with insulin.
364 outpatients recruited 2-5 mos. after the first medical
examination without acute hosp. admission. 174, patients
excluded, d/t medication changes. N = 190 study
participants. 66, pts. not prescribed medications. – diet
management only. 124 patients; prior prescribed an
antidiabetic agent. Female = 100 (52%). Male = 90 (47.4%).
Ages 18-80 y.o. to manage blood glucose. Mean age = 56 
10.6 years. Mean BMI: 24.4  3.3 kg. Most overweight /
obese. Managing blood glucose with DM education alone –
no change in an oral agent.
961 patients eligible after EMR chart review. 651 patients
excluded d/t inability to reach patient / participate, d/t
transportation/child-care issues, or lack of interest. 310
patients screened by bi-lingual/cultural assistants. N: 207.
Control grp: 103. Intervention grp: 104. Aged 21-75 y.o.
Underinsured at an FQCHC in San Diego with dx. DM2 &
A1c >8%.
170 participants with DM2 & no prior DM2 formal
education. 154 (91%) completed the 2-wk. session. 122
(72%) completed the 3-mos. session. 92 (54%) completed
the entire 6-mos. program. 50% (43 of 87) in the group
setting completed the whole program. 59% (49 of 83) in
individual settings completed the entire program. Group
arm: 87 participants. Intervention arm: 83 participants. Ages
30-80 y.o. No identifiable language barrier or known mental
disability.
523 patients were invited. 160 replied & eligible. N: 146
participants with MD confirmed DM dx. Ages 18+ & under
the care of a PCP within 3 yrs. Intervention arm: 73. Control
arm: 73. Age range: 40-75 yrs. All white-Norwegians.

SUMMARY OF SIGNIFICANT FINDINGS

QUALITY
RATING

Patients who participated had a statistically significant decrease in mean A1c levels
(primary outcome). Mean A1c decreased from 8.7% to 7.4%. Delivered high-quality care
and CHW’s, helped to serve as support systems between patients and PCP’s. [1.7(A)],
[3.2(A)], [4.3(A)], [5.1(A)], [5.4(A)], [6.2(E)], [6.5a(A)], [8.6(A)]

II-B

At 14 months, X-PERT patients demonstrated statistically significant greater reduction in
A1c (primary outcome). These patients had a reduced need for diabetes medication.
Improved and increased dietary intake of fruits and vegetables. Enjoyment in healthy food.
Demonstrated greater knowledge r/t DM, improved self-empowerment/self-management,
and reported tx. satisfaction. [1.7(A)], [3.2(A)], [4.3(A)], [5.1(A)], [5.4(A)], [6.2(E)],
[6.5a(A)], [7.2(B)], [7.4(B)], [8.6(A)]

I-A

DM education not effective in patients who visited the hospital for the first time, not being
prescribed antidiabetic agents. Contrary to the non-antidiabetic agent group, the patients
on antidiabetic agents; education had a marked effect. Specifically, those with a dx.  1 yr.
Patients with a shorter duration of dx. education may be far more effective. Patients with
dx. 5+ years showed a slight decrease; therefore, these patients' higher doses or medication
changes were more effective than intensive education. [1.7(A)], [3.2(A)], [4.3(A)],
[5.1(A)], [5.4(A)], [6.2(E)], [6.5a(A)], [7.4(B)], [8.6(A)]

III-B

Culturally sensitive, peer-led Edu. program demonstrated improvement in blood glucose
& metabolic control. Suggests a low-cost approach to self-management & Edu. for highrisk DM patients is clinically effective. A1c decreases from baseline to month 4. A1c
decreased from baseline to month 10. Attendance precipitated improvement in A1c at both
months 4 and 10. [1.7(A)], [3.2(A)], [4.3(A)], [5.1(A)], [5.4(A)], [6.2(E)], [6.5a(A)],
[7.4(B], [8.6(A)]

I-B

When participants completed the program in both settings (group/individual), outcomes
related to knowledge, weight, BMI, attitude, and mental health-related quality of life
significantly improved. A1c decreased in both. The difference in A1c improvement was
marginally greater in subjects assigned to the group education arm. A1c improvement
observed in both Group & Individual. End of the study, 80% of subjects had an A1c <7%.
The study demonstrates, group & individual DM Edu. is equally effective. Satisfies patient
needs & reasons that DM Edu. programs should consider regular use of group education
programs. [1.7(A)], [3.2(A)], [4.3(A)], [5.1(A)], [5.4(A)], [6.2(E)], [6.5a(A)], [7.4(B)],
[8.6(A)]
The Control group had a statistically significant worsening of A1c from baseline to 12mos. Both groups improved DM knowledge from baseline to 12 mos. Higher level of tx.
satisfaction at 6 mos. No statistically significant effect between groups on A1c, but the
control arm worsened significantly. Unchanged in the intervention arm. The intervention
arm showed better DM knowledge & improved self-management. Ongoing DM self-

I-B

I-B
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EDUCATION FOR DM2
Median time since dx= 5yrs. Exclusion for those who
PATIENTS.
attended an Edu. program within the past 12 mos.
INTERVENTION #2: SELF-MONITORING BLOOD GLUCOSE LEVELS
G. IMPROVED
Strowig &
22 adult patients with DM1. 11 men & 11 women. Average
GLYCEMIC CONTROL IN
Raskin
age 33 y.o. Mean duration of DM 9.6 yrs. Mean course of
INTENSIVELY TREATED
(1998)
intensive therapy 3 years at the start of the study.
TYPE 1 DIABETIC
PATIENTS USING BLOOD
GLUCOSE METERS WITH
STORAGE CAPABILITY
AND COMPUTERASSISTED ANALYSES.
H. STRUCTURED SELFPolonsky et
483 poorly controlled DM patients with A1c  7.5%, and
MONITORING OF BLOOD
al. (2011)
insulin naive. Duration of DM> 1 year. Aged  25 y. o. A1c
GLUCOSE
between 7.5% & 12.0%. Active in diet/exercise/meds.
SIGNIFICANTLY
Ability to read/write English. No participation in another
REDUCES A1C LEVELS
study within the past 30 days. Active control group: 227.
IN POORLY
Structured testing group: 256.
CONTROLLED
NONINSULIN-TREATED
TYPE 2 DIABETICS
I. IMPLEMENTATION
Nadkarni, A. 276 participants. Mean age: 62 y.o. 60% of participants were
PLANS AND SELF(2009)
female. Both African Americans and Caucasians are equally
MONITORING OF BLOOD
represented.
GLUCOSE IN DIABETICS

management Edu. programs prevent an increase in A1c & better DM knowledge. [1.7(A)],
[3.2(A)], [4.3(A)], [5.1(A)], [5.4(A)], [6.2(E)], [6.5a(A)], [7.4(B)], [8.6(A)]
Using a blood glucose meter with memory in conjunction with computer-generated
analysis of blood glucose results can lead to improved glycemic control. [4.3(A)],
[5.1(A)], [5.4(A)], [6.2(E)], 6.5a(A)], [7.2(B)], [7.4(B)]

II-B

The 12 mos. follow up from baseline, intent to treat analysis revealed a significantly
greater reduction in mean A1c in the intervention group or structured testing group (STG)
than the active control group (ACG). These results suggest, when patients are monitoring
their blood glucose levels more frequently & bringing that information to the doctor’s
office, blood glucose levels improve, & providers can adjust medications sooner & more
effectively. STG patients received a tx. change by PCP @ 1- mos. visit d/t structured
blood glucose log availability. [4.3(A)], [5.1(A)], [5.4(A)], [6.2(E)], 6.5a(A)], [7.4(B)]

I-B

Making implementation plans increases self-monitoring blood glucose (SMBG) rates.
Goal desire is a precursor to goal intentions; thus, implementation desire &
implementation intentions mediate a pathway between goal intentions and health behavior
performance. Making specific plans to perform self-monitoring blood glucose can
effectively increase the rate of SMBG levels in diabetic patients. [4.3(A)], [5.1(A)],
[5.4(A)], [6.2(E)], 6.5a(A)], [7.2(B)], [7.4(B)]

V-B

INTERVENTION # 3: NUTRITION/DIET
J. THE DIABETES
NUTRITION EDUCATION
STUDY RCT: A
COMPARATIVE
EFFECTIVENESS STUDY
OF APPROACHES TO
NUTRITION IN DIABETES
SELF-MANAGEMENT
EDUCATION

Bowen et al.
(2016)

N: 150 enrolled & randomized. English speaking aged 18-85
with diabetes. Most recent A1c  7% & no formal DM2
Edu. in the past year. Median duration of DM2 dx. was 8
yrs. Patients actively counted carbs, using plate method,
insulin, poor visual acuity, dementia/psychosis, & life
expectancy < 1 yr. excluded. Control: 50. Plate Method: 50.
Carb counting: 50. Median age: 55. Female (53%). NonWhite (34%). 25% < H.S. education. 11% < 9th grade
education.

K. STANDARDS OF
MEDICAL CARE IN
DIABETES – 2021
ABRIDGED FOR
PRIMARY CARE
PROVIDERS

American
Diabetes
Association
(2021)

ADA serves as a nationally recognized & heavily evidencebased resource for leading diabetic care in the US Updated
& published annually. Guidelines developed by physicians,
diabetes educators, & other expert diabetes health care
professionals. ADA’s grading system: A, B, C, or E shows
the evidence level that supports each recommendation.

Change in A1c at 6 mos. (3 mos. after completion of the intervention), between the control I-B
group & each of the 2 intervention groups (modified plate or carb counting). Those with
A1c 7-10% - modified plate method, carb. counting & CDE delivered nutrition
intervention significantly improved glycemic control compared with the control group. All
patients may have significant improvement in A1c using the modified plate method. Even
including low numeracy, all patients may benefit from simplified approaches to nutrition
education. + change in patient weight, self-efficacy, and treatment satisfaction at 6 months
between control and intervention groups. Consistent with national DSME/S guidelines, it
suggests that the approach to DM education needs to be customized to patient
characteristics. [3.2(A), [3.3(A)], [4.3(A)], [5.1(A)], [5.4(A)], [8.6(A)], [8.9(C)]
1.7: Support self-management – coaches/navigators/health workers (A). 3.2: Intensive lifestyle
behavior change to maintain 7% loss of wt. (A). 3.3: Diet to prevent DM (B). 4.3: Patient engagement
in care plan (A). 5.1: All Diabetics should be supported to participate in DSMES (A). 5.4: DSMES
should be pt. centered [group/individual] (A). 6.2: Assess glycemic status at least quarterly & PRN (E).
6.5a: Adult A1c goal of <7% (A). 7.2: Pts. on insulin using SMBG should test when appropriate based
on regimen (B). 7.4: SMBG may help to guide tx. decisions. (B). 8.6: High-frequency counseling &
diet changes (A). 8.9: Evaluate systemic, structural, & socioeconomic factors affecting diet pattern (C).
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Appendix B – Figure 1: External Mapping Tool

Clinical Microsystem:
Adult diabetic patients in a Family Practice FQHC.

Physician
(MD/DO)

Referral
Coordinators

Subpopulation:
Uncontrolled type 2 diabetics in an FQHC with
A1c  10% or F/RBG  200.

Patient Specific Needs:
1.
2.
3.
4.
5.
6.
7.
8.
9.

Education.
Participation in treatment plan.
Medication Management.
Metabolic/Lab Results & Understanding Chronic
Condition.
Easy Scheduling of Appointments.
3-6 months follow-up visits.
Access to Nutrition and Diet modifying services /
Wellness.
Medication &Disease specific education (Diabetes
Educator).
Health Literacy Assistance.

Specialists
outside of
Medical Home

Managed Care /
Insurance /
Billing

Podiatry

Pharmacy
Services

Underserved &
Disadvantaged
Adult Patients
with
Uncontrolled
Type 2
Diabetes
Mellitus in an
FQHC

Dentistry

Monitoring logs: Blood Glucose.
Regular Dietician visits.
Food/Meal prep & cooking classes.
Exercise & Movement Programs.
Medication Minders or facilitators.
Weekly DM2 classes.
Health & Wellness coaches.

Dietician &
Nutritionist

Ophthalmology /
Retinal / Eye
Care

Laboratory
Services
(Primex/Quest)

Family Members
and Caregivers

Improvement Ideas:
1.
2.
3.
4.
5.
6.
7.

Advanced
Practice
Providers
(NP/PA)

Assistive Staff
(LVN/MA)

Administration /
Front Desk /
Scheduling
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Appendix C – Figure 2: Cause & Effect “Fishbone” Diagram

Patient

Community / Social
Determinants of Health

Providers

Mental Health / Depression

Physicians (MD/DO), Advance

Socio-Economic Status & Available

/ Denial & Cultural Beliefs

Practice Providers (NP, PA)

Community Resources

Pharmacist / Dietician / Podiatrist /

Ownership over Diagnosis &

Non-Clinical Staff,

Genetic predisposition & Household

Disease, Medication, Diet Knowledge

Sedentary vs. Active

RN’s, LVN’s, MA’s

influences r/t diet & lifestyle.

Family Members & Friends

ETOH / Nicotine Substance Use?

Ophthalmologist / Phlebotomist

Attentiveness to tx. Management

Time, Full Schedule, Varying

Insured/Underinsured

degrees of attention to guidelines.

vs. Uninsured

Fragmented care by

Safe access to Gym or Exercise Equipment

varying providers.
Transportation & Child/Elder Care
Health care system
difficult to navigate.

Blood Glucose Monitoring Equipment

Short office appt. slots
Access to Education & Wellness Resources

(15 min.)
EHR capabilities: Lacking

Food desert vs. Availability

Resources
Freewordtemplates.net

tracking of care guidelines.

System

Uncontrolled
Type 2 Diabetes
within an FQHC
among
underserved &
disadvantaged
adult patients.
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Appendix D – Figure 3: Force Field Analysis

Current driving forces
High number of
Uncontrolled
Type 2 diabetics
with A1C 10 &
up when
benchmarked
with other
FQHC’s in the
area.

Trending
pattern of
movement
toward
reimbursements
tied to
improved
patient
outcomes.

Providers
incentivized to
see volume
over providing
high quality
care.
___________
Time
constraint.

Ineffective EHR
related to
tracking Care
Guidelines &
uncontrolled
diabetic patient
adherence.

Providers &
Leadership
favoring
tighter
control over
diabetic’s
A1C’s.

Financial &
Economic
resources are
limited for many
patients. Chronic
dx. management
takes a “back
seat”

Current restraining forces

Potential driving forces
Greater
control = less
provider
contact /
involvement
as well as less
intermittent
tasking.
Lighten
provider load.

Potential for a
quality-based
incentive for
providers.
_________
Multidiscipline
collaboration.

Healthier
patients with
less chronic
illness & less tax
on healthcare
system. Reduced
use of acute care
facilities.

Lack of
patient
engagement
& / or
participation
with selfmonitoring.

Finance,
resources, or
patients lost
to follow up.
___________
Covid as a
Competing
constraint.

Tight time
constraint for
observing
significant
change(s) in
glycemic
control.

Potential restraining forces

Daily selfmonitoring of
blood glucose
levels in
underserved &
disadvantaged
Type 2 diabetics
within an urban
FQHC
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Appendix E – Figure 4: Self-Monitoring of Blood Glucose Clinical Pathway / Flowsheet
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Appendix F – Table 2: Measures Table
Aims or Objectives

Outcomes

Measures
How to operationalize/measure Aims
or Objectives

Identify eligible
patients with an A1c
≥ 10% or F/RBS ≥
200.

Screen all diabetic
patients with a (POCT)
A1c or F/RBG.

95% of eligible DM2 patients will be
screened with a (POCT) A1c or
R/FBS.

EMR & pilot
provider schedule.

Enroll eligible
patients with an A1c
≥ 10% or F/RBS ≥
200.

Patients with an A1c of
10% will be offered
the option to participate
in the SMBG program
at each health care visit
and enrolled in the
SMBG program.

75% of DM2 patients with an A1c of
10% will agree to participate in the
daily SMBG program.

EMR & pilot
provider schedule.

Integrate an
evidence-based
intervention: Daily
patient SelfMonitoring of
Blood Glucose
(SMBG) into each
diabetic patient
encounter.

Patients engage in
keeping a daily SMBG
log for 6 months.

75 % of patients enrolled will keep a
daily SMBG log & will have an A1c
in the FQHC every 3 months over a
6-month time frame. For a total of 3
A1c readings in 6 months.

SMBG logs –
scanned into the
patient’s chart.

Where to Find the
Information?

Is there a
Comparison?
No.

No.

At initiation & conclusion, the
provider assesses the patient’s
commitment to managing diabetes &
supplement with DM2 education or
supportive care.

Frequency, proportion, change scores
& run chart(s).
[# of diabetics participating  # of
diabetics with A1c  10%]

No.

Evaluate patients’ blood glucose logs
at each monthly follow-up visit and
observe consistent participation, using
frequency and percentage.
[# of patients who had an A1c every
90 days  number of patients utilizing
intervention]

75% of patients participating will
keep a SMBG log and bring it to the
clinic at f/u appts.

Patients with
uncontrolled DM2 will
demonstrate improved
chronic dx—
management behaviors.

Frequency, proportion, change scores
& run chart(s).
[# screened with A1c/BG  total # of
diabetics seen by pilot provider]

[# of patients categorized as meeting 4
days per week glucose readings 
total number of diabetic patients
utilizing intervention]

[Participation defined as 4 days out of
7 with a documented SMBG reading.]

Promote patient
engagement with
active participation
in daily SMBG and
promote self-care
behaviors.

Analysis
Analysis

Patient pre-and
post-surveys.

Yes – Pre compared
to Post questionnaire
responses.

Assess each patient’s participation by
reviewing questionnaires with Likert
scales & yes / no responses.
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80 % of participants will report
healthy self-care activities: keeping
SMBG log, eating healthy, making
adjustments based on SMBG levels,
& regular exercising.
Patients will be
satisfied with
engagement in selfcare and the SMBG
program.

Patients will become
more comfortable with
driving selfmanagement behaviors
such as daily blood
glucose checks.

90% of participants will complete a
5-8 question survey at initiation &
completion of 6 months. Survey to
assess the rate, frequency, and quality
of blood glucose monitoring and
perceived participation in DM2 selfcare.

Questionnaires
housed in exam
rooms will be
completed before
leaving the office
at the initiation of
the SMBG
program.

Yes – Pre compared
to Post questionnaire
responses.

Compare the Pre & Post-intervention
questionnaires to assess patient
engagement with the SMBG
intervention and how patients
perceived their participation in DM
self-care.

Informed by
patient self-report.
Staff will express
confidence with the
use of the SMBG
clinical pathway.

FQHC staff will be
comfortable utilizing
the clinical pathway for
diabetic care visits.

80 % of staff will reflect an interest in
utilizing the clinical pathway in the
future.

Surveys to be
given to staff after
the intervention.

Patients will achieve
reduced A1c or
F/RBG levels.

Obtain diabetic control
over blood glucose
levels and A1c.

Decrease A1c (POCT) by 2 points
within 6 months.

EMR
demonstrating an
A1c improvement
of 2% points
reduction.

At least 80% of participants will
demonstrate improved blood glucose
control with A1c decreased by 2%
points.

No.

Pre & Post
comparison of
glycemic control in
participants A1c.

Assess staff interest levels in future
participation based on survey
responses.

Assess for 2%-point improvement in
A1c by the 6-month mark.
[Info Needed: Baseline, 3 mos. & 6
mos. A1c]
[Subtract 3-month from baseline =
change score, then  by baseline and
then x by 100 for %]
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Appendix G – Table 3: Clinical Quality Improvement Checklist

CLINICAL QUALITY IMPROVEMENT CHECKLIST
Date: 4/1/2021

Project Leader: Brian Kozaczka

Project Title: Uncontrolled Type 2 Diabetes in a FQHC: Increased Glucose Monitoring for
Glucose Control
Institution where the project will be conducted: South Central Family Health Center
(FQHC)
Instructions: Answer YES or NO to each of the following statements about QI
projects.
The specific aim is to improve the process or deliver of care with established/
accepted practice standards, or to implement change according to mandates of
the health facilities’ Quality Improvement programs. There is no intention of
using the data for research purposes.
The project is NOT designed to answer a research question or test a
hypothesis and is NOT intended to develop or contribute to generalizable
knowledge.
The project does NOT follow a research design (e.g., hypothesis testing or
group comparison [randomization, control groups, prospective comparison
groups, cross-sectional, case control]). The project does NOT follow a
protocol that over-rides clinical decision-making.
The project involves implementation of established and tested practice
standards (evidence-based practice) and/or systematic monitoring, assessment
or evaluation of the organization to ensure that existing quality standards are
being met. The project does NOT develop paradigms or untested methods or
new untested standards.
The project involves implementation or care practices and interventions that
are consensus-based or evidence-based. The project does NOT seek to test an
intervention that is beyond current science and experience.
The project has been discussed with the QA/QI department where the project
will be conducted and involves staff who are working at, or
patients/clients/individuals who are seen at the facility where the project will
be carried out.
The project has NO funding from federal agencies or research-focused
organizations and is not receiving funding for implementation research.
The clinical practice unit (hospital, clinic, division, or care group) agrees that
this is a QI project that will be implemented to improve the process or delivery
of care.

YES
X

X

X

X

X

X

X
X

NO
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The project leader/DNP student has discussed and reviewed the checklist with
the project Course Faculty. The project leader/DNP student will NOT refer to
the project as research in any written or oral presentations or publications.

X

ANSWER KEY: If the answer to ALL of these questions is YES, the activity can be
considered a Clinical Quality Improvement activity that does not meet the definition of human
research. UMB IRB review is not required. Keep a dated copy of the checklist in your
files. If the answer to ANY of these questions is NO, the project must be submitted to the IRB
for review.
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Appendix H – Patient Post-Survey
Directions: When thinking about your diabetes care over the past three (3) months, read each of the questions below
and respond as honestly as possible. The survey is anonymous, and you do not need to identify yourself. Place an
(X) in the box that most accurately describes your feedback response to the questions (Q1 – Q8). You may also
write in comments to reflect your responses in the comment section.
Strongly
Agree /
Neutral Disagree /
Strongly
Comments:
Agree /
Confident
Somewhat Disagree /
Very
Confident
Not Very
Confident
Confident
or “Yes”
at All or
“No”
Considering the SMBG Clinical
5
4
3
2
1
Pathway and Program:
Q1.

How confident are you that you
know when to see the doctor
based on changes with your
diabetes?

Q2.

I was able to obtain a blood
glucose monitor, test strips and
lancets.
I was able to check my blood
glucose every day and record the
results in my home blood glucose
log.

Q3.

Q4.

Knowing my daily blood glucose
results helped me to know when
to see my health care provider
based on changes in blood
glucose levels.

Q5.

I am more confident that I
understand what to do at home,
when my blood glucose levels are
abnormal, as compared to before I
started measuring my blood
glucose daily.

Q6.

I feel as if my diabetes has
improved over the past 3 months.

Q7.

Overall, I was satisfied with daily
blood glucose monitoring.

Q8.

If, I could change anything about
my diabetic care at SCFHC, it
would be:
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Appendix I – Staff Post-Intervention Staff/Employee Survey
Directions: When reflecting on the delivery of care to uncontrolled diabetics over the past three months, read and respond as
honestly as possible. Place an (X) in the box that most accurately describes your feedback response to the questions (Q1 – Q9).
You may also write in comments to reflect your responses in the comment section. Discipline: MA__ Nurse __ Provider __.

Considering the SMBG Clinical
Pathway and Program:
Q1.

The diabetes SMBG program was
realistic, practical, easy to work
with and fit within the 15-minute
office visit.

Q2.

It was easy to identify an
uncontrolled diabetic patient using
the SMBG Clinical Pathway.

Q3.

Once an uncontrolled diabetic
patient had been identified, I felt
empowered to suggest the patient
participate in daily blood glucose
monitoring.

Q4.

Checking patient’s POCT blood
glucose or A1c, and then reporting
and recording the results in the
EMR was clear and concise.

Q5.

Patients typically returned to the
office with their home blood
glucose logs when asked.

Q6.

When patients monitor and record
their blood glucose daily, this
practice adds value to the patient
care experience and promotes
diabetic glucose control.

Q7.

In the future, I am confident that I
could apply the clinical pathway to
all uncontrolled diabetic patients
and could continue to identify and
enroll uncontrolled diabetics if
every given the chance to.

Q8.

What went well with the SMBG
Clinical Pathway Intervention?

Q9.

What did not go so well with the
SMBG Clinical Pathway
Intervention?

Strongly
Agree
5

Agree

Neutral

Disagree

4

3

2

Strongly
Disagree
1

Comments:
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